March 04, 2015 12:15 AM ET


Company Overview of InfaCare Pharmaceutical Corporation

Company Overview

InfaCare Pharmaceutical Corporation develops and commercializes pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a pharmacological treatment for infantile jaundice or hyperbilirubinemia. The company was founded in 2001 and is based in Trevose, Pennsylvania.

8 Neshaminy Interplex

Suite 221

Trevose, PA 19053-6499

United States

Founded in 2001





Key Executives for InfaCare Pharmaceutical Corporation

Chief Executive Officer, President and Director
Age: 62
Founder and Chairman
Age: 70
Chief Financial Officer
Chief Medical Officer
Board Observer
Age: 44
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
CutisPharma Inc. United States
AAIPharma Services Corp. United States
Lantibio, Inc. United States
Arsanis, Inc. United States
Bridgesite Clinical Research United States

Recent Private Companies Transactions

Private Placement
December 8, 2014
Private Placement
October 20, 2014
Private Placement
June 5, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InfaCare Pharmaceutical Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at